Related references
Note: Only part of the references are listed.Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
Erik Portelius et al.
ACTA NEUROPATHOLOGICA (2018)
Synaptic dysfunction and altered excitability in C90RF72 ALS/FTD
Alexander Starr et al.
BRAIN RESEARCH (2018)
Cerebrospinal fluid markers of extracellular matrix remodelling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy
E. Fernstrom et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
Ross W. Paterson et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
Henrietta Wellington et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
Bruno Becker et al.
MOLECULAR NEURODEGENERATION (2018)
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
Ione O. C. Woollacott et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study
Simone Lista et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Imaging and fluid biomarkers in frontotemporal dementia
Lieke H. Meeter et al.
NATURE REVIEWS NEUROLOGY (2017)
Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease
Edward J. Goetzl et al.
FASEB JOURNAL (2016)
Increased CSF neurogranin concentration is specific to Alzheimer disease
Henrietta Wellington et al.
NEUROLOGY (2016)
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
Annika Ohrfelt et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease
Hlin Kvartsberg et al.
ALZHEIMERS & DEMENTIA (2015)
C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
Ann De Vos et al.
ALZHEIMERS & DEMENTIA (2015)
Neurogranin Levels in Cerebrospinal Fluid A New Addition to the Alzheimer Disease Diagnostic Toolbox
Henrik Zetterberg et al.
JAMA NEUROLOGY (2015)
The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
Kaj Blennow et al.
Frontiers in Neuroscience (2015)
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
Ann Brinkmalm et al.
MOLECULAR NEURODEGENERATION (2014)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Differential Expression of SNAP-25 Family Proteins in the Mouse Brain
Saori Yamamori et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2011)
Classification of primary progressive aphasia and its variants
M. L. Gorno-Tempini et al.
NEUROLOGY (2011)
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
Annika Thorsell et al.
BRAIN RESEARCH (2010)
Synaptotagmins in Neurodegeneration
Gordana Glavan et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2009)
Both total and phosphorylated tau are increased in Alzheimer's disease
M Sjögren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Share Paper
